Details for Patent: 10,624,906
✉ Email this page to a colleague
Which drugs does patent 10,624,906 protect, and when does it expire?
Patent 10,624,906 protects CAROSPIR and is included in one NDA.
This patent has four patent family members in four countries.
Summary for Patent: 10,624,906
| Title: | Spironolactone aqueous compositions |
| Abstract: | Disclosed herein is a stable, ready-to-use liquid formulation comprising spironolactone and its method of use. |
| Inventor(s): | Anthony Pipho, Michael Paul DeHart |
| Assignee: | Mayne Pharma Inc dba Metrics Contract Services , CMP Development LLC |
| Application Number: | US16/682,477 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,624,906 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Compound; |
Drugs Protected by US Patent 10,624,906
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cmp Dev Llc | CAROSPIR | spironolactone | SUSPENSION;ORAL | 209478-001 | Aug 4, 2017 | AB | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,624,906
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 3003028 | ⤷ Start Trial | |||
| European Patent Office | 3368045 | ⤷ Start Trial | |||
| Morocco | 43132 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
